Concepedia

Susanne Herndlhofer

SH

Statistics

Publications

26

Citations

1.6K

H-Index

19

Active since

2007

Affiliations

Medical University of Vienna(Current)

Ludwig Boltzmann Institute for Cardiovascular Research

University of Veterinary Medicine Vienna

Austrian Academy of Sciences

CeMM Research Center for Molecular Medicine

Susanne Herndlhofer is an author at Medical University of Vienna specializing in oncology, medicine, and molecular oncology.

Publications per year

2007–2021

26

Publications

26

Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML

Karl J. Aichberger, Susanne Herndlhofer, G. Schernthaner et al. · American Journal of Hematology · 2011 · 300 citations

Medicine, Hematology, Pharmacology +13

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

Harald Herrmann, Irina Sadovnik, Sabine Cerny‐Reiterer et al. · Blood · 2014 · 216 citations · Full text

Medicine, Hematology, Oncology +13

Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site

Emir Hadzijusufovic, Karin Albrecht-Schgoer, K. Huber et al. · Leukemia · 2017 · 155 citations · Full text

Veterinary Medicine, Molecular Medicine, Pharmacotherapy +13

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

Christian Sillaber, Harald Herrmann, Keiryn L. Bennett et al. · European Journal of Clinical Investigation · 2009 · 105 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML

Harald Herrmann, Irina Sadovnik, Gregor Eisenwort et al. · Blood Advances · 2020 · 105 citations · Full text

Life Sciences, Cell Biology, Oncology +17

1–5 of 26